tirzepatide february 2025 vs Semaglutide Tirzepatide Delivers in SURMOUNT-2 -

Genetic variants such as GLP1R rs6923761 and GIPR rs1800437 may predict stronger or weaker receptor signaling, affecting weight-loss magnitude and gastrointestinal symptom intensity

This aggressive titration schedule may contribute to the higher side effect rates seen in early treatment weeks

**General Recommendations for Postpartum Weight Management:** * Prioritize gentle recovery, adequate sleep (as much as possible!), balanced nutrition (especially if breastfeeding), and gradual return to exercise as advised by your doctor

Participants could not have more than a 5 kg change in body weight in the 3 months before screening or be taking another anti-obesity medication

June 2021